Stromal cell derived factor-1 (CXCL12) chemokine gene variant in myeloid leukemias.
HM El-Ghany, ZA El-Saadany, NM Bahaa… - Clinical …, 2014 - europepmc.org
Background Acute and chronic myeloid leukemia are initiated and sustained by a small, self-
renewing population of leukemic stem cells, which produce progeny of a heterogeneous …
renewing population of leukemic stem cells, which produce progeny of a heterogeneous …
Pretransplant mobilization with granulocyte colony-stimulating factor improves B-cell reconstitution by lentiviral vector gene therapy in SCID-X1 mice
MW Huston, ARA Riegman, R Yadak… - Human gene …, 2014 - liebertpub.com
Hematopoietic stem cell (HSC) gene therapy is a demonstrated effective treatment for X-
linked severe combined immunodeficiency (SCID-X1), but B-cell reconstitution and function …
linked severe combined immunodeficiency (SCID-X1), but B-cell reconstitution and function …
Is targeted therapy feasible in acute myelogenous leukemia?
H Konig, M Levis - Current hematologic malignancy reports, 2014 - Springer
The prognosis for patients with acute myeloid leukemia (AML) is determined to a large
degree by the biology of the leukemic cell. In recent years, the identification and …
degree by the biology of the leukemic cell. In recent years, the identification and …
Plasma elevation of vascular endothelial growth factor leads to the reduction of mouse hematopoietic and mesenchymal stem/progenitor cells in the bone marrow
K Tashiro, A Nonaka, N Hirata… - Stem cells and …, 2014 - liebertpub.com
Vascular endothelial growth factor (VEGF) is reported to exhibit potent hematopoietic
stem/progenitor cell (HSPC) mobilization activity. However, the detailed mechanisms of …
stem/progenitor cell (HSPC) mobilization activity. However, the detailed mechanisms of …
干细胞救治缺血性肾损伤: 基质细胞衍生因子1-CXCR4/CXCR7 轴功效特征
达阳， 孟秋宏， 刘宏宝， 薛武军 - 中国组织工程研究, 2014 - cjter.com
背景: 干细胞移植救治缺血性肾损伤是目前的研究热点之一, 但是移植细胞向受损组织体内定居
不足和在受损组织内的存活能力低下是影响其最佳治疗学潜力的两大障碍. 大量研究结果显示 …
不足和在受损组织内的存活能力低下是影响其最佳治疗学潜力的两大障碍. 大量研究结果显示 …
[PDF][PDF] Seizures as an adverse event of cellular therapy in pediatric neurological disorders and its prevention
A Sharma, H Sane, A Paranjape, N Gokulchandran… - J Neurol Disord, 2014 - neurogen.in
This study reports seizures as an adverse event (AE) in children with neurological diseases
treated with autologous bone marrow mononuclear cells (BMMNCs) intrathecal …
treated with autologous bone marrow mononuclear cells (BMMNCs) intrathecal …
A novel approach for the enumeration of Peripheral Blood Stem Cells suitable for Transplantation
W Costa Pereira, O Alsuhaibani… - Journal of …, 2014 - Wiley Online Library
Stem cells have the capability to proliferate and differentiate into various cells of the body.
Few stem cell sources have been approved for transplantation, among them are the …
Few stem cell sources have been approved for transplantation, among them are the …